Navigation Links
Marrone Bio Innovations Breaks Ground on Michigan Manufacturing Facility
Date:8/21/2012

BANGOR, Mich., Aug. 21, 2012 /PRNewswire/ -- Marrone Bio Innovations Inc. (MBI), a leading global provider of natural pest management products for the agricultural and water treatment markets, today announced the groundbreaking of the Marrone Michigan Manufacturing facility in Bangor, Michigan. MBI CEO Pam Marrone was joined by Senator Debbie Stabenow, Chairwoman of the Senate Committee on Agriculture, Nutrition and Forestry, and Bangor Mayor Jennifer Carpio-Zeller to celebrate the occasion. As a bio-based manufacturer, MBI is precisely the type of company that Senator Stabenow is looking to bring to Michigan.

(Photo: http://photos.prnewswire.com/prnh/20120821/SF60295)

MBI's acquisition of the Bangor facility marks the expansion of its manufacturing strategy to accommodate long-term growth and is expected to bring 50 new jobs to the region over the next few years. The 11-acre, 11,000-square-foot manufacturing site is a former biodiesel manufacturing plant that MBI plans to repurpose to produce natural pest management products, or biopesticides, for the agriculture and water treatment markets beginning in early 2013.

"Michigan's business-friendly climate and the support of Senator Stabenow, Mayor Carpio-Zeller, the Michigan Economic Development Corporation, Southwest Michigan First and other state officials played an important role in MBI's decision to expand here. We are particularly grateful to Senator Stabenow, who was instrumental in making us aware of the many advantages and potential incentives available in Michigan," said MBI CEO Pam Marrone. "We expect that having a U.S.-based facility with access to a highly skilled workforce in Michigan will allow us to maintain an exemplary level of quality control as we manufacture our products. This is extremely important as we seek to commercialize additional products, grow our production capacity and serve our worldwide customers and distribution partners."

"When we grow things here and make things here, we create jobs here in Michigan," said Senator Stabenow. "Businesses like MBI are strengthening our economy with new job opportunities in bio-based manufacturing, an area poised for growth in Michigan. As Senate Agriculture Chairwoman, I met with MBI and strongly urged them to locate in Michigan. MBI is precisely the type of innovative bio-based business Michigan is attracting, which will not only create new high-tech jobs of the future but also help protect our Great Lakes and waterways from invasive zebra mussels."

The Bangor facility will complement MBI's existing third-party manufacturing relationships. Initially, MBI plans to manufacture two of its most recently introduced products at the new site: Grandevo®, a broad-spectrum bioinsecticide for controlling insects and mites, and Zequanox®, the first naturally derived product for the control of invasive zebra and quagga mussels. Zequanox® holds particular importance for Michigan, as invasive zebra and quagga mussels have invaded freshwater lakes and rivers throughout the state, creating an enormous and costly problem for industrial and commercial water sources. MBI has several other early stage products that it plans to manufacture in Bangor once approved by the EPA.

About Marrone Bio Innovations

Marrone Bio Innovations, Inc. is a leading global provider of natural pest management products (biopesticides) for the agricultural and water treatment markets. Its effective and environmentally friendly natural agricultural products provide higher yields and quality while managing pest resistance and residues. Through its proprietary discovery and development platform and strategically in-licensed technologies, MBI has developed a pipeline of advanced and early-stage products for the significant agricultural and water treatment markets, including several nematicide, fungicide, algaecide and plant health product candidates. MBI's award-winning products for the agricultural market include the biofungicide Regalia®, and Grandevo®, a broad-spectrum bioinsecticide for controlling insects and mites. The company recently received EPA approval of a novel bioherbicide, and has submitted another broad-spectrum insecticide to the EPA. MBI is launching into the water treatment market with Zequanox®, the industry's first natural product to selectively control invasive zebra and quagga mussels. MBI currently has more than three dozen patents pending in the U.S. and globally.


'/>"/>
SOURCE Marrone Bio Innovations, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Heartland Plant Innovations Wins Kansas Bioscience Authority Funding
2. Air Innovations’ Environmental Control Projects Featured in Trade Media
3. 2012 Hannover Messe: Innovations by KIT
4. ARUP Laboratories Announces Creation of Business Innovations Division
5. Nanoantennas show promise in optical innovations
6. Michael Cusumano, MITs Sloan Distinguished Professor of Management, Joins Quantum Leap Innovations Board of Directors
7. Tropical Storm Debby Pounds Florida With Heavy Rain. Green Bean Buddy Gives Reason Why Home Owners Should Prepare For Mold Outbreaks
8. Soundbites Breaks Through at 47th AES Conference
9. US Lab Deployed to Boost Mexicos Response to Outbreaks of Infectious Disease
10. Scientists Discover How a Bacterial Pathogen Breaks Down Barriers to Enter and Infect Cells
11. Biggest Names in Pharmaceutical, Healthcare Industry to Gather for Groundbreaking Event in Parsippany, New Jersey on September 11-12, 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/7/2017)... ... October 06, 2017 , ... ... Hi-C metagenome deconvolution product, featuring the first commercially available Hi-C kit. Researchers ... perform Hi-C metagenome deconvolution using their own facilities, supplementing the company’s full-service ...
(Date:10/6/2017)... ... October 06, 2017 , ... The HealthTech Venture Network ... at their fourth annual Conference where founders, investors, innovative practitioners and collaborators are ... pitch competition showcasing early stage digital health and med tech companies. , This ...
(Date:10/5/2017)... ... ... LabRoots , the leading provider of educational and interactive virtual events ... cancer research with a month-long promotion supporting the advancement of breast cancer research with ... promo code PinkRibbon to get 10 percent off their purchase of every the “Cancer ...
(Date:10/5/2017)... ... October 05, 2017 , ... NIH ... of its Nanobind DNA/RNA extraction technology . Nanobind is a novel magnetic ... surface and that can be used for a wide variety of sample preparation ...
Breaking Biology Technology:
(Date:3/30/2017)... The research team of The Hong Kong Polytechnic University (PolyU) ... ground breaking 3D fingerprint minutiae recovery and matching technology, pushing contactless ... use in identification, crime investigation, immigration control, security of access and ... ... A research team led by Dr Ajay Kumar ...
(Date:3/29/2017)...  higi, the health IT company that operates the ... , today announced a Series B investment from ... The new investment and acquisition accelerates higi,s strategy to ... population health activities through the collection and workflow integration ... collects and secures data today on behalf of over ...
(Date:3/27/2017)... , March 27, 2017  Catholic Health ... and Management Systems Society (HIMSS) Analytics for achieving ... Adoption Model sm . In addition, CHS previously ... U.S. hospitals using an electronic medical record (EMR). ... its high level of EMR usage in an ...
Breaking Biology News(10 mins):